C23H32N6OSi
Neat
436.64
941685-41-2; (S)-3-Cyclopentyl-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2, 3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile; Ruxolitinib Impurity C; Ruxolitinib Impurity 186; 7XML97PTT2; SCHEMBL100595; QHQSWYIJDFMBNE-NRFANRHFSA-N; (3S)-3-cyclopentyl-3-{4-[7-(2-trimethylsilanylethoxymethyl)-7H-pyrrolo[2, 3-d]pyrimidin-4-yl]pyrazol-1-yl}propionitrile; (betaS)-beta-Cyclopentyl-4-[7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2, 3-d]pyrimidin-4-yl]-1H-pyrazole-1-propanenitrile; 1H-Pyrazole-1-propanenitrile beta-cyclopentyl-4-[7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2, 3-d]pyrimidin-4-yl]-, (betaS)-; 1H-Pyrazole-1-propanenitrile, beta-cyclopentyl-4-[7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2, 3-d]pyrimidin-4-yl]-, (betaS)-; beta-Cyclopentyl-4-[7-[[2-(trimethylsilyl)ethoxy]methyl]-7H-pyrrolo[2, 3-d]pyrimidin-4-yl]-1H-pyrazole-1-propanenitrile and (betaS)-
(3S)-3-cyclopentyl-3-[4-[7-(2-trimethylsilylethoxymethyl)pyrrolo[2 and 3-d]pyrimidin-4-yl]pyrazol-1-yl]propanenitrile
InChI=1S/C23H32N6OSi/c1-31(2,3)13-12-30-17-28-11-9-20-22(25-16-26-23(20)28)19-14-27-29(15-19)21(8-10-24)18-6-4-5-7-18/h9,11,14-16,18,21H,4-8,12-13,17H2,1-3H3/t21-/m0/s1